Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Papp

Showing results (191-200 of 460) with videos related to

Pageof 46
Sort By:
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|June 25, 2011
Direct effects of chemoradiotherapy following esophagectomyS Marton, V Juhasz, L Bogar, et al.
Dermatology and Therapy|October 21, 2022
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical TrialsJonathan I Silverberg, Mark Boguniewicz, Jon Hanifin, et al.
Orvosi Hetilap|December 31, 1997
[Incidence and mortality of aortic dissection]I Mészáros, J Mórocz, J Szlávi, et al.
Biological Psychiatry|November 1, 1990
High-dose carbon dioxide challenge test in anxiety disorder patientsJ M Gorman, L A Papp, J Martinez, et al.
Methods and Findings in Experimental and Clinical Pharmacology|October 3, 2009
In vitro pharmacology of inosine, with special reference to possible interactions with capsaicin-sensitive mechanisms and inflammatory mediatorsM Wolf, R Benko, S Undi, et al.
The New England Journal of Medicine|October 28, 2011
A 52-week trial comparing briakinumab with methotrexate in patients with psoriasisKristian Reich, Richard G Langley, Kim A Papp, et al.
The British Journal of Dermatology|September 13, 2018
Granulocyte-macrophage colony-stimulating factor (GM-CSF) as a therapeutic target in psoriasis: randomized, controlled investigation using namilumab, a specific human anti-GM-CSF monoclonal antibodyK A Papp, M Gooderham, R Jenkins, et al.
Journal of the American Academy of Dermatology|February 21, 2006
Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasisKim A Papp, Bruce Miller, Kenneth B Gordon, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|February 21, 2015
[Accuracy and relevance of CT volumetry in open ocular injuries with intraocular foreign bodies]O A Maneschg, E Volek, Z Lohinai, et al.
The British Journal of Dermatology|December 1, 2007
Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasisD Revicki, M K Willian, J-H Saurat, et al.
Pageof 46

Showing results (191-200 of 460) with videos related to

Sort By:
Pageof 46
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|June 25, 2011
Direct effects of chemoradiotherapy following esophagectomyS Marton, V Juhasz, L Bogar, et al.
Dermatology and Therapy|October 21, 2022
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical TrialsJonathan I Silverberg, Mark Boguniewicz, Jon Hanifin, et al.
Orvosi Hetilap|December 31, 1997
[Incidence and mortality of aortic dissection]I Mészáros, J Mórocz, J Szlávi, et al.
Biological Psychiatry|November 1, 1990
High-dose carbon dioxide challenge test in anxiety disorder patientsJ M Gorman, L A Papp, J Martinez, et al.
Methods and Findings in Experimental and Clinical Pharmacology|October 3, 2009
In vitro pharmacology of inosine, with special reference to possible interactions with capsaicin-sensitive mechanisms and inflammatory mediatorsM Wolf, R Benko, S Undi, et al.
The New England Journal of Medicine|October 28, 2011
A 52-week trial comparing briakinumab with methotrexate in patients with psoriasisKristian Reich, Richard G Langley, Kim A Papp, et al.
The British Journal of Dermatology|September 13, 2018
Granulocyte-macrophage colony-stimulating factor (GM-CSF) as a therapeutic target in psoriasis: randomized, controlled investigation using namilumab, a specific human anti-GM-CSF monoclonal antibodyK A Papp, M Gooderham, R Jenkins, et al.
Journal of the American Academy of Dermatology|February 21, 2006
Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasisKim A Papp, Bruce Miller, Kenneth B Gordon, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|February 21, 2015
[Accuracy and relevance of CT volumetry in open ocular injuries with intraocular foreign bodies]O A Maneschg, E Volek, Z Lohinai, et al.
The British Journal of Dermatology|December 1, 2007
Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasisD Revicki, M K Willian, J-H Saurat, et al.
Pageof 46